Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Onartuzumab with or without bevacizumab in combination with weekly paclitaxel does not prolong QTc or adversely affect other ECG parameters in patients with locally recurrent or metastatic triple-negative breast cancer.
Cancer Chemother Pharmacol. 2015 Feb;75(2):401-10. doi: 10.1007/s00280-014-2652-0. Epub 2014 Dec 27.
Cancer Chemother Pharmacol. 2015.
PMID: 25542267
Clinical Trial.
Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program.
Morley R, Cardenas A, Hawkins P, Suzuki Y, Paton V, Phan SC, Merchant M, Hsu J, Yu W, Xia Q, Koralek D, Luhn P, Aldairy W.
Morley R, et al. Among authors: aldairy w.
PLoS One. 2015 Oct 7;10(10):e0139679. doi: 10.1371/journal.pone.0139679. eCollection 2015.
PLoS One. 2015.
PMID: 26445503
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.